Target Price | €61.20 |
Price | €57.00 |
Potential |
7.37%
register free of charge
|
Number of Estimates | 19 |
19 Analysts have issued a price target Carl Zeiss Meditec 2026 .
The average Carl Zeiss Meditec target price is €61.20.
This is
7.37%
register free of charge
€94.50
65.79%
register free of charge
€53.53
6.09%
register free of charge
|
|
A rating was issued by 22 analysts: 9 Analysts recommend Carl Zeiss Meditec to buy, 12 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Carl Zeiss Meditec stock has an average upside potential 2026 of
7.37%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 2.07 | 2.21 |
1.11% | 7.16% | |
EBITDA Margin | 15.84% | 17.86% |
21.63% | 12.77% | |
Net Margin | 8.65% | 7.54% |
37.76% | 12.84% |
21 Analysts have issued a sales forecast Carl Zeiss Meditec 2025 . The average Carl Zeiss Meditec sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Carl Zeiss Meditec EBITDA forecast 2025. The average Carl Zeiss Meditec EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
21 Carl Zeiss Meditec Analysts have issued a net profit forecast 2025. The average Carl Zeiss Meditec net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 2.01 | 1.91 |
38.15% | 4.98% | |
P/E | 29.89 | |
EV/Sales | 2.52 |
21 Analysts have issued a Carl Zeiss Meditec forecast for earnings per share. The average Carl Zeiss Meditec EPS is
This results in the following potential growth metrics and future valuations:
Carl Zeiss Meditec...
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
EQUITA SIM |
Locked
➜
Locked
|
Locked | Feb 16 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Mar 19 2025 |
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Mar 11 2025 |
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Mar 04 2025 |
Locked
EQUITA SIM:
Locked
➜
Locked
|
Feb 16 2025 |
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Feb 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.